Citigroup’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
Citigroup's LGND Position: Q3 2026 in Review
Citigroup increased its Ligand Pharmaceuticals (LGND) stake by 95% in Q3 2026, buying an estimated $18.7M and bringing the position to 129,988 shares worth $40.6M. The position accounts for 0.01% of the portfolio, ranked #855.
Citigroup first reported a position in LGND in Q2 2013 and has held it in 54 quarters since. 433 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- Citigroup held 129,988 shares of Ligand Pharmaceuticals worth $40.6M as of Q3 2026.
- Citigroup bought 63,349 Ligand Pharmaceuticals shares in Q3 2026, an estimated $18.7M.
- Ligand Pharmaceuticals made up 0.01% of Citigroup's portfolio in Q3 2026, its #855 holding.
- Citigroup first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 54 quarters since.
- 433 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.